{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:36:10Z","timestamp":1790620570248,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00115-023-01446-y","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T15:03:13Z","timestamp":1677596593000},"page":"250-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Digitale Gesundheitsanwendungen mit psychotherapeutischem Fokus","Prescription-based digital interventions in psychiatry"],"prefix":"10.1007","volume":"94","author":[{"given":"Matthias","family":"Guth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Philipsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"1446_CR1","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2020) Pressemitteilung Nummer 4\/20 vom 06.10.2020 \u2013 BfArM nimmt erste \u201eApps auf Rezept\u201c ins Verzeichnis digitaler Gesundheitsanwendungen (DiGA) auf. https:\/\/www.bfarm.de\/SharedDocs\/Pressemitteilungen\/DE\/2020\/pm4-2020.html. Zugegriffen: 19. Jan. 2023"},{"key":"1446_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00115-021-01196-9","volume":"92","author":"EC Weitzel","year":"2021","unstructured":"Weitzel\u00a0EC, Quittschalle\u00a0J, Welzel\u00a0FD et al (2021) E\u2011Mental-Health und digitale Gesundheitsanwendungen in Deutschland. Nervenarzt 92:1121\u20131129","journal-title":"Nervenarzt"},{"key":"1446_CR3","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) DiGA-Verzeichnis. https:\/\/diga.bfarm.de\/de\/verzeichnis\/. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR4","volume-title":"Internationale Klassifikation psychischer St\u00f6rungen: ICD-10, Kapitel V (F) \u2013 klinisch-diagnostische Leitlinien","author":"H Dilling","year":"2015","unstructured":"Dilling\u00a0H, Mombour\u00a0W, Schmidt\u00a0M et al (2015) Internationale Klassifikation psychischer St\u00f6rungen: ICD-10, Kapitel V (F) \u2013 klinisch-diagnostische Leitlinien. Hogrefe, G\u00f6ttingen"},{"key":"1446_CR5","unstructured":"Bundesministerium f\u00fcr Gesundheit (2022) Digitale Gesundheitsanwendungen (DiGA). https:\/\/www.bundesgesundheitsministerium.de\/themen\/krankenversicherung\/online-ratgeber-krankenversicherung\/arznei-heil-und-hilfsmittel\/digitale-gesundheitsanwendungen.html. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR6","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) Das Fast-Track-Verfahren f\u00fcr digitale Gesundheitsanwendungen (DiGA) nach \u00a7 139e SGB V, Version 3.1. https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Medizinprodukte\/diga_leitfaden.pdf?__blob=publicationFile. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR7","unstructured":"GKV-Spitzenverband (2021) Bericht des GKV-Spitzenverbandes \u00fcber die Inanspruchnahme und Entwicklung der Versorgung mit Digitalen Gesundheitsanwendungen gem\u00e4\u00df \u00a7 33a Absatz 6 SGB V, Berichtszeitraum: 01.09.2020 \u2013 30.09.2021. https:\/\/www.gkv-spitzenverband.de\/media\/dokumente\/krankenversicherung_1\/telematik\/digitales\/2021_DiGA_Bericht_final_barrierefrei.pdf. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR8","volume-title":"McKinsey & Company E-Health Monitor 2022","author":"L Maier","year":"2022","unstructured":"Maier\u00a0L, Messal\u00a0H, M\u00fcller\u00a0T et al (2022) Akzeptanz und Nutzung digitaler Gesundheitsl\u00f6sungen. In: M\u00fcller\u00a0T, Padmanabhan\u00a0P, Richter\u00a0L, Silberzahn\u00a0T (Hrsg) McKinsey & Company E\u2011Health Monitor 2022. MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin"},{"key":"1446_CR9","unstructured":"Techniker Krankenkasse (2022) DiGA-Report 2022. https:\/\/www.tk.de\/resource\/blob\/2125136\/dd3d3dbafcfaef0984dcf8576b1d7713\/tk-diga-report-2022-data.pdf. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s00103-021-03409-7","volume":"64","author":"W Lauer","year":"2021","unstructured":"Lauer\u00a0W, L\u00f6bker\u00a0W, H\u00f6fgen\u00a0B (2021) Digitale Gesundheitsanwendungen (DiGA): Bewertung der Erstattungsf\u00e4higkeit mittels DiGA-Fast-Track-Verfahrens im Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 64:1232\u20131240","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1446_CR11","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2022) App \u201ezanadio\u201c bei Adipositas: Neue GOP zur Verlaufskontrolle. https:\/\/www.kbv.de\/html\/1150_61164.php. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR12","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) HelloBetter ratiopharm chronischer Schmerz \u2013 Information f\u00fcr Fachkreise. https:\/\/diga.bfarm.de\/de\/verzeichnis\/1304\/fachkreise. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR13","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) Kranus Edera \u2013 Information f\u00fcr Fachkreise. https:\/\/diga.bfarm.de\/de\/verzeichnis\/1282\/fachkreise. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR14","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) Optimune \u2013 Information f\u00fcr Fachkreise. https:\/\/diga.bfarm.de\/de\/verzeichnis\/1613\/fachkreise. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR15","doi-asserted-by":"publisher","DOI":"10.1026\/02867-000","volume-title":"Expositionsbasierte Therapie der Panikst\u00f6rung mit Agoraphobie: Ein Behandlungsmanual","author":"T Lang","year":"2018","unstructured":"Lang\u00a0T, Helbig-Lang\u00a0S, Westphal\u00a0D et al (2018) Expositionsbasierte Therapie der Panikst\u00f6rung mit Agoraphobie: Ein Behandlungsmanual. Hogrefe, G\u00f6ttingen"},{"key":"1446_CR16","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) Invirto \u2013 Die Therapie gegen Angst \u2013 Information f\u00fcr Fachkreise. https:\/\/diga.bfarm.de\/de\/verzeichnis\/300\/fachkreise. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jad.2020.06.059","volume":"276","author":"M Domhardt","year":"2020","unstructured":"Domhardt\u00a0M, Letsch\u00a0J, Kybelka\u00a0J et al (2020) Are Internet- and mobile-based interventions effective in adults with diagnosed panic disorder and\/or agoraphobia? A systematic review and meta-analysis. J\u00a0Affect Disord 276:169\u2013182","journal-title":"J Affect Disord"},{"key":"1446_CR18","doi-asserted-by":"publisher","first-page":"100364","DOI":"10.1016\/j.invent.2021.100364","volume":"24","author":"M Polak","year":"2021","unstructured":"Polak\u00a0M, Tanzer\u00a0NK, Bauernhofer\u00a0K et al (2021) Disorder-specific internet-based cognitive-behavioral therapy in treating panic disorder, comorbid symptoms and improving quality of life: a meta-analytic evaluation of randomized controlled trials. Internet Interv 24:100364","journal-title":"Internet Interv"},{"key":"1446_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.janxdis.2018.03.009","volume":"56","author":"AM Ciuca","year":"2018","unstructured":"Ciuca\u00a0AM, Berger\u00a0T, Cri\u015fan\u00a0LG et al (2018) Internet-based treatment for panic disorder: a three-arm randomized controlled trial comparing guided (via real-time video sessions) with unguided self-help treatment and a\u00a0waitlist control. PAXPD study results. J\u00a0Anxiety Disord 56:43\u201355","journal-title":"J Anxiety Disord"},{"key":"1446_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/16506073.2016.1163615","volume":"45","author":"P Oromendia","year":"2016","unstructured":"Oromendia\u00a0P, Orrego\u00a0J, Bonillo\u00a0A et al (2016) Internet-based self-help treatment for panic disorder: a\u00a0randomized controlled trial comparing mandatory versus optional complementary psychological support. Cogn Behav Ther 45:270\u2013286","journal-title":"Cogn Behav Ther"},{"key":"1446_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.janxdis.2016.03.005","volume":"39","author":"VJ Fogliati","year":"2016","unstructured":"Fogliati\u00a0VJ, Dear\u00a0BF, Staples\u00a0LG et al (2016) Disorder-specific versus transdiagnostic and clinician-guided versus self-guided internet-delivered treatment for panic disorder and comorbid disorders: a randomized controlled trial. J\u00a0Anxiety Disord 39:88\u2013102","journal-title":"J Anxiety Disord"},{"key":"1446_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.janxdis.2016.09.012","volume":"44","author":"E Ivanova","year":"2016","unstructured":"Ivanova\u00a0E, Lindner\u00a0P, Ly\u00a0KH et\u00a0al (2016) Guided and unguided acceptance and commitment therapy for social anxiety disorder and\/or panic disorder provided via the Internet and a\u00a0smartphone application: a randomized controlled trial. J\u00a0Anxiety Disord 44:27\u201335","journal-title":"J Anxiety Disord"},{"key":"1446_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/16506070802561132","volume":"38","author":"B Klein","year":"2009","unstructured":"Klein\u00a0B, Austin\u00a0D, Pier\u00a0C et al (2009) Internet-based treatment for panic disorder: does frequency of therapist contact make a\u00a0difference? Cogn Behav Ther 38:100\u2013113","journal-title":"Cogn Behav Ther"},{"key":"1446_CR24","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.janxdis.2021.102382","volume":"79","author":"EP Stech","year":"2021","unstructured":"Stech\u00a0EP, Chen\u00a0AZ, Sharrock\u00a0MJ et al (2021) Internet-delivered exposure therapy versus internet-delivered cognitive behavioral therapy for panic disorder: A pilot randomized controlled trial. J\u00a0Anxiety Disord 79:102382","journal-title":"J Anxiety Disord"},{"key":"1446_CR25","doi-asserted-by":"publisher","first-page":"e30590","DOI":"10.2196\/30590","volume":"8","author":"B Shin","year":"2021","unstructured":"Shin\u00a0B, Oh\u00a0J, Kim\u00a0B\u2011H et al (2021) Effectiveness of self-guided virtual reality-based cognitive behavioral therapy for panic disorder: randomized controlled trial. JMIR Ment Health 8:e30590","journal-title":"JMIR Ment Health"},{"key":"1446_CR26","unstructured":"Bandelow B, Aden I, Alpers GW et al (2021) Deutsche S3-Leitlinie Behandlung von Angstst\u00f6rungen, Version 2. www.awmf.org\/leitlinien\/detail\/ll\/051-028.html.. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR27","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) HelloBetter Panik \u2013 Information f\u00fcr Fachkreise. https:\/\/diga.bfarm.de\/de\/verzeichnis\/1513\/fachkreise. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR28","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) velibra \u2013 Information f\u00fcr Fachkreise. https:\/\/diga.bfarm.de\/de\/verzeichnis\/316\/fachkreise. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR29","doi-asserted-by":"publisher","first-page":"e20829","DOI":"10.2196\/20829","volume":"23","author":"L Ebenfeld","year":"2021","unstructured":"Ebenfeld\u00a0L, Lehr\u00a0D, Ebert\u00a0DD et al (2021) Evaluating a\u00a0hybrid web-based training program for panic disorder and agoraphobia: randomized controlled trial. J\u00a0Med Internet Res 23:e20829","journal-title":"J Med Internet Res"},{"key":"1446_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1017\/S0033291716002270","volume":"47","author":"T Berger","year":"2017","unstructured":"Berger\u00a0T, Urech\u00a0A, Krieger\u00a0T et\u00a0al (2017) Effects of a\u00a0transdiagnostic unguided Internet intervention (\u2018velibra\u2019) for anxiety disorders in primary care: results of a\u00a0randomized controlled trial. Psychol Med 47:67\u201380","journal-title":"Psychol Med"},{"key":"1446_CR31","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) Mindable: Panikst\u00f6rung und Agoraphobie \u2013 Information f\u00fcr Fachkreise. https:\/\/diga.bfarm.de\/de\/verzeichnis\/329\/fachkreise. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR32","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2022) DiGA: F\u00fcr Leistungserbringer. https:\/\/diga.bfarm.de\/de\/leistungserbringer. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR33","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2022) Digitale Gesundheitsanwendungen: Hinweise zur Verordnung, Abrechnung und Verg\u00fctung. https:\/\/www.kbv.de\/media\/sp\/PraxisInfo_Digitale_Gesundheitsanwendungen.pdf. Zugegriffen: 7. Dez. 2022"},{"key":"1446_CR34","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2022) Rahmenvertrag \u00fcber ein Entlassmanagement beim \u00dcbergang in die Versorgung nach Krankenhausbehandlung nach \u00a7 39 Abs.\u00a01a SGB V (Rahmenvertrag Entlassmanagement) in der Fassung der 8. \u00c4nderungsvereinbarung vom 01.03.2022. https:\/\/www.kbv.de\/media\/sp\/Rahmenvertrag_Entlassmanagement.pdf. Zugegriffen: 7. Dez. 2022"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-023-01446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-023-01446-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-023-01446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T12:05:22Z","timestamp":1678190722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-023-01446-y"}},"subtitle":["Therapieprinzipien, Einsatzm\u00f6glichkeiten, rechtlicher Rahmen und Verordnungspraxis am Beispiel der Anwendungen f\u00fcr die Panikst\u00f6rung und Agoraphobie","Methodology, possible areas of application, and legal framework of digital tools for panic disorder and agoraphobia available in Germany"],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s00115-023-01446-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"20 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>M.\u00a0Guth:<\/b> A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Erstellung von Evaluationskonzepten f\u00fcr DiGA im Bereich chronische Schmerzen und Schlaf f\u00fcr den Hersteller HelloBetter im Rahmen der T\u00e4tigkeit am Universit\u00e4tsklinikum Bonn (siehe unten).\u00a0\u2013 Vortragst\u00e4tigkeit zu DiGA f\u00fcr die CGM Mobile Services GmbH (Hersteller von Praxisverwaltungssystemen).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Arzt, Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Bonn\u00a0| im Rahmen dieser T\u00e4tigkeit Durchf\u00fchrung einer Evaluationsstudie f\u00fcr die DiGA Mindable; die Studie wird aus Haushaltsmitteln des Universit\u00e4tsklinikums Bonn finanziert und unabh\u00e4ngig vom Hersteller publiziert | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e.\u202fV.<b>A. Wiebe:<\/b> A. Finanzielle Interessen: A. Wiebe gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Wissenschaftliche Besch\u00e4ftigte in der Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie, Universit\u00e4tsklinikum Bonn | Durchf\u00fchrung einer Evaluationsstudie f\u00fcr die DiGA Mindable; die Studie wird aus Haushaltsmitteln des Universit\u00e4tsklinikums Bonn finanziert und unabh\u00e4ngig vom Hersteller publiziert.<b>A. Philipsen: <\/b>A. Finanzielle Interessen: BMBF, EU (Horizon2020), Medice Arzneimittel, NIHR, Rotary Club Bonn (Spende). \u2013 AdBoards und Vortr\u00e4ge: Medice, B\u00f6hringer, Takeda; Kongresssponsoring: Janssen-Cilag; Moderatorin f\u00fcr PsychiatrieLive (Mischsponsoring); Vortragst\u00e4tigkeit MedUpdate (Mischsponsoring). \u2013 Beratert\u00e4tigkeit: Medice, Takeda, B\u00f6hringer, Janssen-Cilag (ab 2021). \u2013 B. Nichtfinanzielle Interessen: Klinikdirektorin der Klinik f\u00fcr Psychiatrie am Uniklinikum Bonn | Wissenschaftlicher Beirat \u201ePsychotherapie\u201c; Herausgeberin \u201eVerhaltenstherapie\u201c.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}